Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

Developing a framework of core competencies in implementation research for low/middle-income countries.

Alonge O, Rao A, Kalbarczyk A, Maher D, Gonzalez Marulanda ER, Sarker M, Ibisomi L, Dako-Gyeke P, Mahendradhata Y, Launois P, Vahedi M.

BMJ Glob Health. 2019 Sep 3;4(5):e001747. doi: 10.1136/bmjgh-2019-001747. eCollection 2019. Review.

2.

Colloidal Stability of Imogolite Nanotube Dispersions: A Phase Diagram Study.

Paineau E, Monet G, Peyre V, Goldmann C, Rouzière S, Launois P.

Langmuir. 2019 Sep 24;35(38):12451-12459. doi: 10.1021/acs.langmuir.9b01922. Epub 2019 Sep 10.

PMID:
31475826
3.

Women's global health leadership in LMICs.

Liu E, Iwelunmor J, Gabagaya G, Anyasi H, Leyton A, Goraleski KA, Wei S, Del Barrio MO, Olaleye A, Launois P, Tucker JD.

Lancet Glob Health. 2019 Sep;7(9):e1172-e1173. doi: 10.1016/S2214-109X(19)30308-0. No abstract available.

4.

Building research capacity through "Planning for Success".

Gómez L, Jaramillo A, Halpaap B, Launois P, Cuervo LG, Saravia NG.

PLoS Negl Trop Dis. 2019 Aug 1;13(8):e0007426. doi: 10.1371/journal.pntd.0007426. eCollection 2019 Aug. No abstract available.

5.

The influence of age on quality of life after upper body burn.

Santacreu E, Grossi L, Launois P, López S, Torrent-Bertran ML, Barret JP.

Burns. 2019 May;45(3):554-559. doi: 10.1016/j.burns.2018.09.016. Epub 2018 Oct 24.

PMID:
31018911
6.

[Spanish validation of the Autonomic Standards Assessment Form in spinal cord injuries].

Montesinos-Magraner L, Castellano-Tejedor C, Frías A, Launois P, Rojas-Cuotto K, González-Viejo MA.

Rehabilitacion (Madr). 2019 Jan - Mar;53(1):20-27. doi: 10.1016/j.rh.2018.10.007. Epub 2018 Dec 7. Spanish.

PMID:
30929829
7.

TLR2 Signaling in Skin Nonhematopoietic Cells Induces Early Neutrophil Recruitment in Response to Leishmania major Infection.

Ronet C, Passelli K, Charmoy M, Scarpellino L, Myburgh E, Hauyon La Torre Y, Turco S, Mottram JC, Fasel N, Luther SA, Beverley SM, Launois P, Tacchini-Cottier F.

J Invest Dermatol. 2019 Jun;139(6):1318-1328. doi: 10.1016/j.jid.2018.12.012. Epub 2018 Dec 27.

PMID:
30594488
8.

Structural resolution of inorganic nanotubes with complex stoichiometry.

Monet G, Amara MS, Rouzière S, Paineau E, Chai Z, Elliott JD, Poli E, Liu LM, Teobaldi G, Launois P.

Nat Commun. 2018 May 23;9(1):2033. doi: 10.1038/s41467-018-04360-z.

9.

Tracking the career development of scientists in low- and middle-income countries trained through TDR's research capacity strengthening programmes: Learning from monitoring and impact evaluation.

Halpaap B, Vahedi M, Certain E, Alvarado T, Saint Martin C, Merle C, Mihut M, Launois P.

PLoS Negl Trop Dis. 2017 Dec 7;11(12):e0006112. doi: 10.1371/journal.pntd.0006112. eCollection 2017 Dec.

10.

Graphene oxide-carbon nanotube hybrid assemblies: cooperatively strengthened OH···O 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 1111111111111111111111111111111111 1111111111111111111111111111111111 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 1111111111111111111111111111111111 1111111111111111111111111111111111 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 C hydrogen bonds and the removal of chemisorbed water.

Núñez JD, Benito AM, Rouzière S, Launois P, Arenal R, Ajayan PM, Maser WK.

Chem Sci. 2017 Jul 1;8(7):4987-4995. doi: 10.1039/c7sc00223h. Epub 2017 May 4.

11.

From the Laboratory to the Field: Updating Capacity Building in Medical Entomology.

Almeida APG, Fouque F, Launois P, Sousa CA, Silveira H.

Trends Parasitol. 2017 Sep;33(9):664-668. doi: 10.1016/j.pt.2017.05.011. Epub 2017 Jun 14.

PMID:
28624159
12.

Developing a globally applicable evidence-informed competency framework to support capacity strengthening in clinical research.

Julé A, Furtado T, Boggs L, van Loggerenberg F, Ewing V, Vahedi M, Launois P, Lang T.

BMJ Glob Health. 2017 Mar 30;2(2):e000229. doi: 10.1136/bmjgh-2016-000229. eCollection 2017. Erratum in: BMJ Glob Health. 2017 Sep 7;2(3):e000229corr1.

13.

Development of the Good Health Research Practice course: ensuring quality across all health research in humans.

Henley P, Elango V, Horstick O, Ahmad RA, Maure C, Launois P, Merle C, Nabieva J, Mahendradhata Y.

Health Res Policy Syst. 2017 Mar 31;15(1):28. doi: 10.1186/s12961-017-0193-9.

14.

Developing the ethics of implementation research in health.

Gopichandran V, Luyckx VA, Biller-Andorno N, Fairchild A, Singh J, Tran N, Saxena A, Launois P, Reis A, Maher D, Vahedi M.

Implement Sci. 2016 Dec 9;11(1):161.

15.

Mapping of courses on vector biology and vector-borne diseases systems: time for a worldwide effort.

Casas J, Lazzari C, Insausti T, Launois P, Fouque F.

Mem Inst Oswaldo Cruz. 2016 Nov;111(11):717-719. doi: 10.1590/0074-02760160295. Epub 2016 Oct 13.

16.

Leishmaniavirus-Dependent Metastatic Leishmaniasis Is Prevented by Blocking IL-17A.

Hartley MA, Bourreau E, Rossi M, Castiglioni P, Eren RO, Prevel F, Couppié P, Hickerson SM, Launois P, Beverley SM, Ronet C, Fasel N.

PLoS Pathog. 2016 Sep 22;12(9):e1005852. doi: 10.1371/journal.ppat.1005852. eCollection 2016 Sep.

17.

Promoting good health research practice in low- and middle-income countries.

Mahendradhata Y, Nabieva J, Ahmad RA, Henley P, Launois P, Merle C, Maure C, Horstick O, Elango V.

Glob Health Action. 2016 Aug 5;9:32474. doi: 10.3402/gha.v9.32474. eCollection 2016.

18.

Water in Carbon Nanotubes: The Peculiar Hydrogen Bond Network Revealed by Infrared Spectroscopy.

Dalla Bernardina S, Paineau E, Brubach JB, Judeinstein P, Rouzière S, Launois P, Roy P.

J Am Chem Soc. 2016 Aug 24;138(33):10437-43. doi: 10.1021/jacs.6b02635. Epub 2016 Aug 12.

PMID:
27455124
19.

Research Capacity Strengthening in Low and Middle Income Countries - An Evaluation of the WHO/TDR Career Development Fellowship Programme.

Käser M, Maure C, Halpaap BM, Vahedi M, Yamaka S, Launois P, Casamitjana N.

PLoS Negl Trop Dis. 2016 May 25;10(5):e0004631. doi: 10.1371/journal.pntd.0004631. eCollection 2016 May.

20.

A liquid-crystalline hexagonal columnar phase in highly-dilute suspensions of imogolite nanotubes.

Paineau E, Krapf ME, Amara MS, Matskova NV, Dozov I, Rouzière S, Thill A, Launois P, Davidson P.

Nat Commun. 2016 Jan 5;7:10271. doi: 10.1038/ncomms10271.

21.

Strengthening research capacity--TDR's evolving experience in low- and middle-income countries.

Ogundahunsi OA, Vahedi M, Kamau EM, Aslanyan G, Terry RF, Zicker F, Launois P.

PLoS Negl Trop Dis. 2015 Jan 8;9(1):e3380. doi: 10.1371/journal.pntd.0003380. eCollection 2015 Jan. No abstract available.

22.

MyD88 and TLR9 dependent immune responses mediate resistance to Leishmania guyanensis infections, irrespective of Leishmania RNA virus burden.

Ives A, Masina S, Castiglioni P, Prével F, Revaz-Breton M, Hartley MA, Launois P, Fasel N, Ronet C.

PLoS One. 2014 May 6;9(5):e96766. doi: 10.1371/journal.pone.0096766. eCollection 2014.

23.

Single-step formation of micron long (OH)3Al2O3Ge(OH) imogolite-like nanotubes.

Amara MS, Paineau E, Bacia-Verloop M, Krapf ME, Davidson P, Belloni L, Levard C, Rose J, Launois P, Thill A.

Chem Commun (Camb). 2013 Dec 14;49(96):11284-6. doi: 10.1039/c3cc46839a. Epub 2013 Oct 24.

PMID:
24153223
24.

Intracellular fate of carbon nanotubes inside murine macrophages: pH-dependent detachment of iron catalyst nanoparticles.

Bussy C, Paineau E, Cambedouzou J, Brun N, Mory C, Fayard B, Salomé M, Pinault M, Huard M, Belade E, Armand L, Boczkowski J, Launois P, Lanone S.

Part Fibre Toxicol. 2013 Jun 25;10:24. doi: 10.1186/1743-8977-10-24.

25.

X-ray scattering determination of the structure of water during carbon nanotube filling.

Paineau E, Albouy PA, Rouzière S, Orecchini A, Rols S, Launois P.

Nano Lett. 2013 Apr 10;13(4):1751-6. doi: 10.1021/nl400331p. Epub 2013 Mar 27.

PMID:
23517435
26.

Critical role of surface chemical modifications induced by length shortening on multi-walled carbon nanotubes-induced toxicity.

Bussy C, Pinault M, Cambedouzou J, Landry MJ, Jegou P, Mayne-L'hermite M, Launois P, Boczkowski J, Lanone S.

Part Fibre Toxicol. 2012 Nov 27;9:46. doi: 10.1186/1743-8977-9-46.

27.

Does T Helper Differentiation Correlate with Resistance or Susceptibility to Infection with L. major? Some Insights From the Murine Model.

Tacchini-Cottier F, Weinkopff T, Launois P.

Front Immunol. 2012 Feb 27;3:32. doi: 10.3389/fimmu.2012.00032. eCollection 2012.

28.

Impact of health research capacity strengthening in low- and middle-income countries: the case of WHO/TDR programmes.

Minja H, Nsanzabana C, Maure C, Hoffmann A, Rumisha S, Ogundahunsi O, Zicker F, Tanner M, Launois P.

PLoS Negl Trop Dis. 2011 Oct;5(10):e1351. doi: 10.1371/journal.pntd.0001351. Epub 2011 Oct 11.

29.

Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis.

Ives A, Ronet C, Prevel F, Ruzzante G, Fuertes-Marraco S, Schutz F, Zangger H, Revaz-Breton M, Lye LF, Hickerson SM, Beverley SM, Acha-Orbea H, Launois P, Fasel N, Masina S.

Science. 2011 Feb 11;331(6018):775-8. doi: 10.1126/science.1199326.

30.

T cell reactivity against mycolyl transferase antigen 85 of M. tuberculosis in HIV-TB coinfected subjects and in AIDS patients suffering from tuberculosis and nontuberculous mycobacterial infections.

Launois P, Drowart A, Bourreau E, Couppie P, Farber CM, Van Vooren JP, Huygen K.

Clin Dev Immunol. 2011;2011. pii: 640309. doi: 10.1155/2011/640309. Epub 2010 Sep 27.

31.

The MyD88 protein 88 pathway is differently involved in immune responses induced by distinct substrains of Leishmania major.

Revaz-Breton M, Ronet C, Ives A, Torre YH, Masina S, Tacchini-Cottier F, Launois P.

Eur J Immunol. 2010 Jun;40(6):1697-707. doi: 10.1002/eji.200939821.

32.

Neutrophil-derived CCL3 is essential for the rapid recruitment of dendritic cells to the site of Leishmania major inoculation in resistant mice.

Charmoy M, Brunner-Agten S, Aebischer D, Auderset F, Launois P, Milon G, Proudfoot AE, Tacchini-Cottier F.

PLoS Pathog. 2010 Feb 5;6(2):e1000755. doi: 10.1371/journal.ppat.1000755.

33.

Regulatory B cells shape the development of Th2 immune responses in BALB/c mice infected with Leishmania major through IL-10 production.

Ronet C, Hauyon-La Torre Y, Revaz-Breton M, Mastelic B, Tacchini-Cottier F, Louis J, Launois P.

J Immunol. 2010 Jan 15;184(2):886-94. doi: 10.4049/jimmunol.0901114. Epub 2009 Dec 4.

34.

A new function of the Fas-FasL pathway in macrophage activation.

Chakour R, Allenbach C, Desgranges F, Charmoy M, Mauel J, Garcia I, Launois P, Louis J, Tacchini-Cottier F.

J Leukoc Biol. 2009 Jul;86(1):81-90. doi: 10.1189/jlb.1008590. Epub 2009 Apr 20.

PMID:
19380712
35.

Intralesional regulatory T-cell suppressive function during human acute and chronic cutaneous leishmaniasis due to Leishmania guyanensis.

Bourreau E, Ronet C, Darcissac E, Lise MC, Sainte Marie D, Clity E, Tacchini-Cottier F, Couppie P, Launois P.

Infect Immun. 2009 Apr;77(4):1465-74. doi: 10.1128/IAI.01398-08. Epub 2009 Jan 21.

36.

In leishmaniasis due to Leishmania guyanensis infection, distinct intralesional interleukin-10 and Foxp3 mRNA expression are associated with unresponsiveness to treatment.

Bourreau E, Ronet C, Darsissac E, Lise MC, Marie DS, Clity E, Tacchini-Cottier F, Couppie P, Launois P.

J Infect Dis. 2009 Feb 15;199(4):576-9. doi: 10.1086/596508.

PMID:
19125672
37.

Cutaneous leishmaniasis: progress towards a vaccine.

Launois P, Tacchini-Cottier F, Kieny MP.

Expert Rev Vaccines. 2008 Oct;7(8):1277-87. doi: 10.1586/14760584.7.8.1277. Review.

PMID:
18844599
38.

Shape-controlled platinum nanocubes and their assembly into two-dimensional and three-dimensional superlattices.

Demortière A, Launois P, Goubet N, Albouy PA, Petit C.

J Phys Chem B. 2008 Nov 20;112(46):14583-92. doi: 10.1021/jp802081n. Epub 2008 Sep 26.

PMID:
18817438
39.

How confinement affects the dynamics of c60 in carbon nanopeapods.

Rols S, Cambedouzou J, Chorro M, Schober H, Agafonov V, Launois P, Davydov V, Rakhmanina AV, Kataura H, Sauvajol JL.

Phys Rev Lett. 2008 Aug 8;101(6):065507. Epub 2008 Aug 8.

PMID:
18764476
40.

Carbon nanotubes in macrophages: imaging and chemical analysis by X-ray fluorescence microscopy.

Bussy C, Cambedouzou J, Lanone S, Leccia E, Heresanu V, Pinault M, Mayne-L'hermite M, Brun N, Mory C, Cotte M, Doucet J, Boczkowski J, Launois P.

Nano Lett. 2008 Sep;8(9):2659-63. doi: 10.1021/nl800914m. Epub 2008 Aug 2.

PMID:
18672943
41.

Leishmania major-specific B cells are necessary for Th2 cell development and susceptibility to L. major LV39 in BALB/c mice.

Ronet C, Voigt H, Himmelrich H, Doucey MA, Hauyon-La Torre Y, Revaz-Breton M, Tacchini-Cottier F, Bron C, Louis J, Launois P.

J Immunol. 2008 Apr 1;180(7):4825-35.

42.

An essential role for transmembrane TNF in the resolution of the inflammatory lesion induced by Leishmania major infection.

Allenbach C, Launois P, Mueller C, Tacchini-Cottier F.

Eur J Immunol. 2008 Mar;38(3):720-31. doi: 10.1002/eji.200737662.

43.

Self-assembled lamellar structures with functionalized single wall carbon nanotubes.

Bhattacharyya S, Salvetat JP, Roy D, Heresanu V, Launois P, Saboungi ML.

Chem Commun (Camb). 2007 Nov 7;(41):4248-50.

PMID:
18217595
44.

Different epitopes of the LACK protein are recognized by V beta 4 V alpha 8 CD4+ T cells in H-2b and H-2d mice susceptible to Leishmania major.

Launois P, Pingel S, Himmelrich H, Locksley R, Louis J.

Microbes Infect. 2007 Sep;9(11):1260-6. Epub 2007 May 27.

PMID:
17890126
45.

Substantial improvement of nanotube processability by freeze-drying.

Maugey M, Neri W, Zakri C, Derré A, Pénicaud A, Noé L, Chorro M, Launois P, Monthioux M, Poulin P.

J Nanosci Nanotechnol. 2007 Aug;7(8):2633-9.

PMID:
17685277
46.

IL-10 producing CD8+ T cells in human infection with Leishmania guyanensis.

Bourreau E, Ronet C, Couppié P, Sainte-Marie D, Tacchini-Cottier F, Launois P.

Microbes Infect. 2007 Jul;9(8):1034-41. Epub 2007 Apr 21.

PMID:
17544800
47.

Leishmania major induces distinct neutrophil phenotypes in mice that are resistant or susceptible to infection.

Charmoy M, Megnekou R, Allenbach C, Zweifel C, Perez C, Monnat K, Breton M, Ronet C, Launois P, Tacchini-Cottier F.

J Leukoc Biol. 2007 Aug;82(2):288-99. Epub 2007 Apr 20.

PMID:
17449725
48.

Selective expression of the V beta 14 T cell receptor on Leishmania guyanensis--specific CD8+ T cells during human infection.

Kariminia A, Bourreau E, Ronet C, Couppie P, Sainte-Marie D, Tacchini-Cottier F, Launois P.

J Infect Dis. 2007 Mar 1;195(5):739-47. Epub 2007 Jan 23.

PMID:
17262718
49.

Macrophages induce neutrophil apoptosis through membrane TNF, a process amplified by Leishmania major.

Allenbach C, Zufferey C, Perez C, Launois P, Mueller C, Tacchini-Cottier F.

J Immunol. 2006 Jun 1;176(11):6656-64.

50.

LACK-reactive CD4+ T cells require autocrine IL-2 to mediate susceptibility to Leishmania major.

Gumy A, Aseffa A, Rachinel N, Breton M, Otten L, Tacchini-Cottier F, Röcken M, Doyen N, Acha-Orbea H, Locksley RM, MacDonald HR, Launois P, Louis J.

Eur J Immunol. 2006 Jun;36(6):1465-73.

Supplemental Content

Loading ...
Support Center